Orthofix’s Integration Efforts Go Smoothly in First Half

Orthofix reported 2Q23 orthopedic sales of $187 million, +58.4% compared to the second quarter of 2022. For the first half, the company generated $362.2 million in orthopedic sales, +61.4% compared to the prior year. Notably, these as-reported results do not include legacy SeaSpine sales for 2022. On a pro forma basis, Orthofix grew +6.8% for...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us